Saxenda® is contraindicated in individuals with a personal or household background of MTC and in individuals with Multiple Endocrine Neoplasia syndrome type 2 (Adult males 2). Counsel clients concerning the possible threat of MTC with utilization of Saxenda® and inform them of symp